High efficacy of the CHOP + rituximab association in a case of primary rectal non-Hodgkin lymphoma (NHL)

Leuk Lymphoma. 2006 Aug;47(8):1686-7. doi: 10.1080/10428190600612636.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Female
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Middle Aged
  • Prednisolone / therapeutic use
  • Rectal Neoplasms / drug therapy*
  • Rituximab
  • Treatment Outcome
  • Vincristine / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone

Supplementary concepts

  • VAP-cyclo protocol